Dimensional Fund Advisors
AXSM icon

Dimensional Fund Advisors’s Axsome Therapeutics AXSM Stock Holding History

Dimensional Fund Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.56M Buy
15,160
+2,729
+22% +$471K ﹤0.01% 2652
2025
Q4 		$2.27M Sell
12,431
-6,761
-35% -$944K ﹤0.01% 2711
2025
Q3 		$2.33M Buy
19,192
+11,849
+161% +$1.33M ﹤0.01% 2733
2025
Q2 		$767K Sell
7,343
-135
-2% -$14.3K ﹤0.01% 2929
2025
Q1 		$872K Buy
+7,478
New +$852K ﹤0.01% 2907

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors's AXSM Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Axsome Therapeutics (AXSM) stake by 22% in Q1 2026, buying an estimated $471K and bringing the position to 15,160 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2652.

Dimensional Fund Advisors first reported a position in AXSM in Q1 2025 and has held it in 5 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Dimensional Fund Advisors held 15,160 shares of Axsome Therapeutics worth $2.56M as of Q1 2026.
  • Dimensional Fund Advisors bought 2,729 Axsome Therapeutics shares in Q1 2026, an estimated $471K.
  • Axsome Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2652 holding.
  • Dimensional Fund Advisors first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.